Cardiac Implant Market Spurring With Rising Geriatric Population Worldwide

Cardiac implants are explicitly intricate devices compared to other medical devices, possessing someone’s heart in their clasp. Cardiac implants either remain inside the patient after they go home which are used only during surgery or over the course of the patient’s stay at the hospital. Pacemakers are eminent examples of cardiac implants. However, the consequences of electromagnetic interference on cardiac implant are potentially calamitous, leading to significant development of standards in the field. For instance, AAMI, the Association for the Advancement of Medical Instrumentation, published EMC test protocols for implantable cardiac pacemakers and implantable cardioverter defibrillators. ISO and IEC, two international standards bodies with extremely broad user bases, participated on a sequence of Information Technology standards, publishing a standard on sequence of the electromagnetic interference impact of ISO/IEC 18000 interrogator emitters on implantable pacemakers and implantable cardioverter defibrillators.

According to Goldstein Research, the cardiac implants market size is set to reach USD 56.59 billion by 2024, at a CAGR of 10.0% over the forecast years. Increasing cases of bradycardia which include congenital heart disease, side effects of certain heart medications, aging, scar tissue from previous heart attack, sick sinus syndrome is driving the global cardiac implant market.

The global cardiac implants market is segmented based on product type and by condition. On the basis of type segment is further categorized into cardiac rhythm management devices, heart valves (artificial & replacement), stents, ventricular assist devices and others (neurostimulator, etc). Among which stents hold the largest market share of 42% of global cardiac implants market due to heart diseases being the number one cause of death and responsible for around 15% of people that have heart attack die from it.

Key players in the cardiac implants market are Abbott Laboratories, Medtronic, Roche, C. R. Bard, Inc, B. Braun Melsungen, Biotronik, Boston Scientific, Elixir Medical Corporation, W. L. Gore & Associates, Bentley InnoMed GmbH, Elestim-Cardio. Recently, MultiCare’s Pulse Heart Institute implanted the world’s smallest pacemaker, a one-piece, pill-sized device that is 93% smaller than conventional pacemaker designs which date back more than 50 years.

The top five countries with the highest rates of heart disease deaths are Russia, Bulgaria, Romania, Hungary and Argentina. Coronary artery disease, a blockage of the arteries that supply blood to the heart, is the most common type of heart disease. About 600,000 people in the United States die from heart disease every year�"that’s one in four deaths. Every year, 715,000 Americans have a heart attack. 15% of people who have a heart attack will die from it. Based on geography, North America leads the cardiac implants market with 47% of total market share in 2016 while Asians and Pacific Islanders are at third-highest risk for a heart disease-related death, at 22.5 %.